Chronic disease area | Study | Quality assessment* | ||||||
Conflict of interest | Study design | Participant selection | Allocation concealment and blinding | Data collection | Attributable to intervention | Appropriate analysis | ||
Diabetes | Dijkstra et al8 | ? | ++ | ++ | + | + | + | + |
Dijkstra et al9 | ? | ++ | ++ | + | + | + | + | |
Dijkstra et al10 | ? | + | ++ | ? | + | + | + | |
Simmons et al11 | − | ++ | ++ | + | + | ++ | + | |
Oncology | Cornbleet et al12 | − | ++ | ++ | − | − | + | + |
Drury et al13 | ? | ++ | ++ | + | − | + | + | |
Lecouturier et al14 | ? | + | ++ | + | − | + | + | |
Williams et al15 | ++ | + | ++ | + | + | + | + | |
Finlay and Wyatt16 | ? | + | − | + | − | + | + | |
van Wersch et al17 | ? | + | + | − | − | + | − | |
Mental health | Lester et al18 | ? | ++ | + | + | + | + | + |
Warner et al19 | ++ | ++ | + | + | + | ++ | + | |
Rheumatoid arthritis | Riemsma et al20 | ? | + | + | + | + | + | + |
Stroke | Ayana et al21 | ? | + | + | − | + | + | + |
Palliative care | Latimer et al22 | ? | ++ | + | ? | − | + | ? |
↵* Quality assessment: ++, criterion met; +, criterion partially met; −, criterion not met; ?, unclear from the information provided.